Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension

  • STATUS
    Recruiting
  • days left to enroll
    33
  • participants needed
    50
  • sponsor
    Medical University of Vienna
Updated on 23 April 2022
hypertension
apnea
sleep disorder
sleep-disordered breathing
obstructive sleep apnea
central sleep apnea, cheyne-stokes breathing
riociguat
central sleep apnea

Summary

There is evidence for a high prevalence of Sleep Disorder Breathing (SDB) in patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Central Sleep Apnea, Cheyne-Stokes Breathing and Obstructive Sleep Apnea appear to occur in CTEPH. However, there is no information on the impact of CTEPH treatment modalities on concomitant SDB. Furthermore, the use of PAP therapy in CTEPH has not yet been investigated. CTEPH is a rare and serious disease and there may be a bidirectional association of SDB and CTEPH.

This study plans to investigate the prevalence of SDB in CTEPH and compare it to datasets of large epidemiological studies on SDB. Furthermore, the impact of CTEPH treatment on SDB will be analyzed and CTEPH patients for possible PAP treatment will be defined.

Details
Condition Chronic Thromboembolic Pulmonary Hypertension, Sleep Disordered Breathing
Treatment Riociguat, Pulmonary Endarteriectomy, Ballon Pulmonary Angioplasty
Clinical Study IdentifierNCT03074539
SponsorMedical University of Vienna
Last Modified on23 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Recently diagnosed untreated CTEPH
NYHA I-III

Exclusion Criteria

Age<18
Pulmonary Hypertension other than CTEPH
Previous diagnosis of SDB
Ongoing PAP treatment
Use of nasal oxygen
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note